Terumo Corp (TRUMY)
17.52
+0.13
(+0.75%)
USD |
OTCM |
May 06, 16:00
Terumo Price to Book Value: 3.017 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 3.017 |
| May 03, 2024 | 2.994 |
| May 02, 2024 | 2.943 |
| May 01, 2024 | 2.877 |
| April 30, 2024 | 2.914 |
| April 29, 2024 | 2.903 |
| April 26, 2024 | 2.858 |
| April 25, 2024 | 2.862 |
| April 24, 2024 | 2.943 |
| April 23, 2024 | 2.936 |
| April 22, 2024 | 2.917 |
| April 19, 2024 | 2.829 |
| April 18, 2024 | 2.842 |
| April 17, 2024 | 2.874 |
| April 16, 2024 | 2.926 |
| April 15, 2024 | 2.846 |
| April 12, 2024 | 2.886 |
| April 11, 2024 | 2.876 |
| April 10, 2024 | 2.898 |
| April 09, 2024 | 2.989 |
| April 08, 2024 | 3.037 |
| April 05, 2024 | 3.016 |
| April 04, 2024 | 3.025 |
| April 03, 2024 | 3.008 |
| April 02, 2024 | 3.087 |
| Date | Value |
|---|---|
| April 01, 2024 | 3.065 |
| March 28, 2024 | 3.167 |
| March 27, 2024 | 3.217 |
| March 26, 2024 | 3.177 |
| March 25, 2024 | 3.140 |
| March 22, 2024 | 3.189 |
| March 21, 2024 | 3.250 |
| March 20, 2024 | 3.265 |
| March 19, 2024 | 3.240 |
| March 18, 2024 | 3.338 |
| March 15, 2024 | 3.295 |
| March 14, 2024 | 3.296 |
| March 13, 2024 | 3.314 |
| March 12, 2024 | 3.344 |
| March 11, 2024 | 3.335 |
| March 08, 2024 | 3.344 |
| March 07, 2024 | 3.388 |
| March 06, 2024 | 3.394 |
| March 05, 2024 | 3.416 |
| March 04, 2024 | 3.412 |
| March 01, 2024 | 3.412 |
| February 29, 2024 | 3.344 |
| February 28, 2024 | 3.334 |
| February 27, 2024 | 3.375 |
| February 26, 2024 | 3.334 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.218
Minimum
Oct 13 2023
4.831
Maximum
Sep 27 2021
3.368
Average
3.414
Median
Sep 10 2019
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.8769 |
| Nxera Pharma Co Ltd | 1.803 |
| PeptiDream Inc | 5.797 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 37.17 |
| PS Ratio | 4.141 |
| PEG Ratio | 5.085 |
| Price to Free Cash Flow | 60.51 |
| Price | 17.52 |
| Earnings Yield | 2.69% |
| Market Cap | 26.01B |
| PEGY Ratio | 4.559 |
| Operating PE Ratio | 28.50 |
| Normalized PE Ratio | 37.17 |